CTC Alternative Strategies’s Amgen AMGN Stock Holding History

CTC Alternative Strategies’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,300	Closed	-$717K	–	146
2025 Q1	$717K	Buy	+2,300	New	+$679K	0.88%	28
2023 Q4	–	Sell	-2,200	Closed	-$591K	–	77
2023 Q3	$591K	Buy	+2,200	New	+$549K	1.12%	31
2013 Q3	–	Sell	-9,300	Closed	-$918K	–	95
2013 Q2	$918K	Buy	+9,300	New	+$965K	0.25%	26

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CTC Alternative Strategies's AMGN Position: Q2 2025 in Review

CTC Alternative Strategies sold out of Amgen (AMGN) in Q2 2025, closing a stake of 2,300 shares — an estimated $717K sold.

CTC Alternative Strategies first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $918K in Q2 2013. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

CTC Alternative Strategies reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
CTC Alternative Strategies sold 2,300 Amgen shares in Q2 2025, an estimated $717K.
CTC Alternative Strategies first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
CTC Alternative Strategies's Amgen position peaked at $918K in Q2 2013.
2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on CTC Alternative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.